Master of Science in Biotechnology
|BIOT 500||Biotechnology Internship||3|
|BIOT 510||Commercialization of Technology||3|
|BIOT 511||Molecular Biology, Pharmacology, and Toxicology of Biopharmaceutics||3|
|BIOT 513||Regulatory Affairs for the Biotechnology Industry||3|
|BIOT 514||Advanced Probability and Statistics||3|
|BIOT 515||Project Management for the Biotechnology Industry||3|
|BIOT 516||Ethics for Biomedical Products Industries||3|
|BIOT 517||Clinical Trials||3|
|BIOT 600A||Master's Degree Project I 1||3|
|BIOT 600B||Master's Degree Project II||9|
BIOT 600A is taken for 3 units in the fall semester of the second year, and BIOT 600B for 9 units in the spring semester of the second year.
BIOT 500, Biotechnology Internship, 3 Units
The Biotechnology Summer Internship is a mandatory component of the Masters Degree in Biotechnology at Azusa Pacific University. It is reserved for students enrolled in the Biotechnology Master of Science Program (BMP). The internship requirement is 320 hours, and generally takes 10-12 weeks to complete. Internships may be paid or unpaid, and are carried out at the business sites of biomedical product companies. Internship projects will be presented at the BMP internship symposium in the Fall semester after the completion of the internship.
Prerequisite: Enrolled and in good standing in the Biotechnology Master of Science degree program.
BIOT 510, Commercialization of Technology, 3 Units
This course serves as an introduction to issues related to new product development, formulating strategies, acquiring resources, setting up and managing operations, and creating technology-focused businesses with an emphasis on ethics in the high-tech workforce environment. Assignments and project focus on learning how to manage and commercialize technology.
Corequisites: BIOT 511, and graduate standing in the biotechnology master's program or consent of program and instructor.
BIOT 511, Molecular Biology, Pharmacology, and Toxicology of Biopharmaceutics, 3 Units
This course is an overview of molecular biology, pharmacology, and toxicology concepts as applied to the development of biopharmaceutical products and biomedical devices. Students work collaboratively toward a final project to propose a new pharmaceutical product and/or biomedical device.
Corequisites: BIOT 510, and graduate standing in the biotechnology master's program or consent of program and instructor.
BIOT 512, Bioinformatics, 3 Units
This course is an introduction to the strategies, approaches, and computer applications used in drug discovery, database design, and data mining. Case studies illustrate specific applications of the methods for measuring, visualizing, representing, inferring, clustering, classifying, and modeling biotechnological data. Class format involves didactic instruction and hands-on experience with various bioinformatics tools and databases.
BIOT 513, Regulatory Affairs for the Biotechnology Industry, 3 Units
This course is a detailed examination of the terminology, timelines, and practices followed by regulatory affairs professionals employed in the biotechnology industry. Case studies from the industry are examined to supplement certain topics and to illustrate interpretation of regulations.
BIOT 514, Advanced Probability and Statistics, 3 Units
This course is an examination of the statistical methods and computer applications used in drug manufacturing processes. Topics covered include data presentation, probability, hypothesis testing, univariate and multivariate analysis, linear regression, and confidence interval estimation.
Prerequisite: Completion of year-one curriculum for the M.S. in Biotechnology degree program.
BIOT 515, Project Management for the Biotechnology Industry, 3 Units
This course is designed to prepare students in business, engineering, and technology for the task of managing projects, such as information technology projects, business process improvement projects, and product development projects.
Prerequisite: Graduate standing in the M.S. in Biotechnology program, or consent of program and instructor.
BIOT 516, Ethics for Biomedical Products Industries, 3 Units
Biotechnology exists at a critical intersection of science and ethics, and the power and potential of biotechnology demands caution to ensure ethical progress. This course examines the ethical roles and responsibilities of key participants in the biomedical development process, including industry, government, and healthcare authorities. Students examine ethical issues related to biomedical product advancement and use, and specific areas of science are also explored from a Christian ethics viewpoint through lectures, student oral presentations, team debate, and final written projects.
BIOT 517, Clinical Trials, 3 Units
This course examines governmental laws, practices, and regulations associated with human clinical trials, and includes development and evaluation of a series of in-class assignments with class discussion and a capstone project for small student groups culminating with in-class presentations.
BIOT 600A, Master's Degree Project I, 3 Units
This 3-unit course comprises the first part of the capstone master's degree project (MDP) for the M.S. in Biotechnology program, and is to be taken in the fall semester of students' second year. In this course, students identify and begin work on the MDP, for which they must complete a minimum of 480 hours of in-person work at a project site approved by the program director - 120 hours in BIOT 600A, and the balance of the hours in the 9-unit BIOT 600B in the spring semester of students' second year.
Prerequisite: Second-year good standing in the M.S. biotechnology program.
BIOT 600B, Master's Degree Project II, 9 Units
This 9-unit course comprises the second part of the capstone master's degree project (MDP) for the M.S. in Biotechnology program, and is to be taken in the spring semester of students' second year. In this course, students must complete the remaining 360 hours of in-person work at a project site approved by the program director, and must also give an oral presentation (defense) and a written report of the project to fulfill the degree requirement.
Prerequisite: Good standing in the M.S. biotechnology program.
David Dyer, Ph.D.